Yıl: 2021 Cilt: 36 Sayı: 2 Sayfa Aralığı: 139 - 145 Metin Dili: Türkçe DOI: 10.5505/tjo.2021.2603 İndeks Tarihi: 04-06-2022

New Molecular Markers in Breast Cancer; Piwi-like protein-2 (PIWIL-2) and DEAD Box Helicase-4 (DDX-4) genes

Öz:
Breast cancer, which basically is the unchecked proliferation of the epithelial cells covering the ductus and the lobules of the breast, is the most common form of cancer in women and ranks second after lung cancer among total deaths from that disease. As all other carcinomas, mamarian cancer results from the progressive accumulation of genetic anomalies. Several genes exist that have been associated positively with breast cancer. We aimed to research the molecular markers about breast cancer’s etiology, screening, treatment, and its follow-up. METHODS Invasive ductal carcinoma from tumoral paraffin tissues and normal breast tissues taken from breast reduction surgeries was used in the study. The study examines the expressions of the PIWIL-2, PIWIL-1, DICER-1, and DDX-4 genes in the invasive ductal carcinoma of the breast. RESULTS As predicted, PIWIL-2 and DDX4 expressions were found to be significantly higher compared to normal tissues. PIWIL-1 expression, on the other hand, was recorded at borderline levels of significance. The expression of DICER-1, a gene responsible for the formation and maturation of microRNAs (miRNAs), revealed no significant difference. CONCLUSION It was concluded that the increased expression of PIWIL-2 and DDX-4 in breast cancer cases that are not detectable in normal tissue enables its use as a marker in the diagnosis and treatment of mamarian cancer and the post-therapy follow-up of the disease. It appears to be more informative to study the specific miRNAs of the gene rather than its expression to discern the function of the DICER-1 gene in breast cancer.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer (Dove Med Press) 2019;11:151–64.
  • 2. Bertucci F, Ng CK, Patsouris A, Droin N, Piscuoglio S, Carbuccia N, et al. Genomic characterization of metastatic breast cancers. Nature 2019;572(7767):E7.
  • 3. Duijf PH, Nanayakkara D, Nones K, Srihari S, Kalimutho M, Khanna KK. Mechanisms of genomic instability in breast cancer. Trends Mol Med 2019;25(7):595–611.
  • 4. Huang Y, Nayak S, Jankowitz R, Davidson NE, Oesterreich S. Epigenetics in breast cancer: what’s new? Breast Cancer Res 2011;13(6):225.
  • 5. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000;406(6797):747–52.
  • 6. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001;98(19):10869–74.
  • 7. Pasculli B, Barbano R, Parrella P. Epigenetics of breast cancer: biology and clinical implication in the era of precision medicine. Semin Cancer Biol 2018;51:22–35.
  • 8. Stefansson OA, Esteller M. Epigenetic modifications in breast cancer and their role in personalized medicine. Am J Pathol 2013;183(4):1052–63.
  • 9. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifentreated, node-negative breast cancer. N Engl J Med 2004;351(27):2817–26.
  • 10. Hock J, Meister G. The Argonaute protein family. Genome Biol 2008;9(2):210.
  • 11. Liu JJ, Shen R, Chen L, Ye Y, He G, Hua K, et al. PIWIL2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker. Int J Clin Exp Pathol 2010;3(4):328–37.
  • 12. Ye Y, Yin DT, Chen L, Zhou Q, Shen R, He G, et al.Identification of PIWIL-2-Like (PL2L) proteins that promote tumorigenesis. PLoS One 2010;5(10):e13406.
  • 13. Lee JH, Schutte D, Wulf G, Fuzesi L, Radzun HJ, Schweyer S, et al. Stem-cell protein PIWIL-2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Hum Mol Genet 2006;15(2):201–11
  • 14. Iwasaki YW, Siomi MC, Siomi H. PIWI-Interacting RNA: Its biogenesis and functions. Annu Rev Biochem 2015;84:405–33.
  • 15. Mentis AF, Dardiotis E, Romas NA, Papavassiliou AG. PIWI family proteins as prognostic markers in cancer: a systematic review and meta-analysis. Cell Mol Life Sci 2020;77(12):2289–314.
  • 16. Li D, Sun X, Yan D, Huang J, Luo Q, Tang H, et al. PIWIL-2 modulates the proliferation and metastasis of colon cancer via regulation of Matrix Metallopeptidase 9 transcriptional activity. Exp Biol Med (Maywood) 2012;237(10):1231–40.
  • 17. Greither T, Koser F, Kappler M, Bache M, Lautenschlager C, Gobel S, et al. Expression of human Piwilike genes is associated with prognosis for soft tissue sarcoma patients. BMC Cancer 2012;12:272.
  • 18. Wang Y, Liu Y, Shen X, Zhang X, Chen X, Yang C, et al. The PIWI protein acts as a predictive marker for human gastric cancer. Int J Clin Exp Pathol 2012;5(4):315–25.
  • 19. Tosun H, Demirtaş A, Sönmez G, Tombul ST, Akalın H, Özkul Y. Can the expression level of PIWIL 2 gene be a serum marker for prostate cancer? a single-center prospective study. Turk J Urol 2019;45(1):S22–5.
  • 20. Nikpour P, Forouzandeh-Moghaddam M, Ziaee SA, Dokun OY, Schulz WA, Mowla SJ. absence of PIWIL2 (HILI) expression in human bladder cancer cell lines and tissues. Cancer Epidemiol 2009;33(3–4):271–5.
  • 21. Taubert H, Wach S, Jung R, Pugia M, Keck B, Bertz S, et al. Piwil 2 expression is correlated with diseasespecific and progression-free survival of chemotherapy- treated bladder cancer patients. Mol Med 2015;21(1):371–80.
  • 22. Gainetdinov IV, Skvortsova YV, Stukacheva EA, Bychenko OS, Kondratieva SA, Zinovieva MV, et al. Expression profiles of PIWIL2 short isoforms differ in testicular germ cell tumors of various differentiation subtypes. PLoS One 2014;9(11):e112528.
  • 23. Schudrowitz N, Takagi S, Wessel GM, Yajima M. Germline factor DDX4 functions in blood-derived cancer cell phenotypes. Cancer Sci 2017;108(8):1612–9.
APA CAG M, ÖZDEMİR Y, ÖZKUL Y (2021). New Molecular Markers in Breast Cancer; Piwi-like protein-2 (PIWIL-2) and DEAD Box Helicase-4 (DDX-4) genes. , 139 - 145. 10.5505/tjo.2021.2603
Chicago CAG MURAT,ÖZDEMİR Yeşim,ÖZKUL Yusuf New Molecular Markers in Breast Cancer; Piwi-like protein-2 (PIWIL-2) and DEAD Box Helicase-4 (DDX-4) genes. (2021): 139 - 145. 10.5505/tjo.2021.2603
MLA CAG MURAT,ÖZDEMİR Yeşim,ÖZKUL Yusuf New Molecular Markers in Breast Cancer; Piwi-like protein-2 (PIWIL-2) and DEAD Box Helicase-4 (DDX-4) genes. , 2021, ss.139 - 145. 10.5505/tjo.2021.2603
AMA CAG M,ÖZDEMİR Y,ÖZKUL Y New Molecular Markers in Breast Cancer; Piwi-like protein-2 (PIWIL-2) and DEAD Box Helicase-4 (DDX-4) genes. . 2021; 139 - 145. 10.5505/tjo.2021.2603
Vancouver CAG M,ÖZDEMİR Y,ÖZKUL Y New Molecular Markers in Breast Cancer; Piwi-like protein-2 (PIWIL-2) and DEAD Box Helicase-4 (DDX-4) genes. . 2021; 139 - 145. 10.5505/tjo.2021.2603
IEEE CAG M,ÖZDEMİR Y,ÖZKUL Y "New Molecular Markers in Breast Cancer; Piwi-like protein-2 (PIWIL-2) and DEAD Box Helicase-4 (DDX-4) genes." , ss.139 - 145, 2021. 10.5505/tjo.2021.2603
ISNAD CAG, MURAT vd. "New Molecular Markers in Breast Cancer; Piwi-like protein-2 (PIWIL-2) and DEAD Box Helicase-4 (DDX-4) genes". (2021), 139-145. https://doi.org/10.5505/tjo.2021.2603
APA CAG M, ÖZDEMİR Y, ÖZKUL Y (2021). New Molecular Markers in Breast Cancer; Piwi-like protein-2 (PIWIL-2) and DEAD Box Helicase-4 (DDX-4) genes. Türk Onkoloji Dergisi, 36(2), 139 - 145. 10.5505/tjo.2021.2603
Chicago CAG MURAT,ÖZDEMİR Yeşim,ÖZKUL Yusuf New Molecular Markers in Breast Cancer; Piwi-like protein-2 (PIWIL-2) and DEAD Box Helicase-4 (DDX-4) genes. Türk Onkoloji Dergisi 36, no.2 (2021): 139 - 145. 10.5505/tjo.2021.2603
MLA CAG MURAT,ÖZDEMİR Yeşim,ÖZKUL Yusuf New Molecular Markers in Breast Cancer; Piwi-like protein-2 (PIWIL-2) and DEAD Box Helicase-4 (DDX-4) genes. Türk Onkoloji Dergisi, vol.36, no.2, 2021, ss.139 - 145. 10.5505/tjo.2021.2603
AMA CAG M,ÖZDEMİR Y,ÖZKUL Y New Molecular Markers in Breast Cancer; Piwi-like protein-2 (PIWIL-2) and DEAD Box Helicase-4 (DDX-4) genes. Türk Onkoloji Dergisi. 2021; 36(2): 139 - 145. 10.5505/tjo.2021.2603
Vancouver CAG M,ÖZDEMİR Y,ÖZKUL Y New Molecular Markers in Breast Cancer; Piwi-like protein-2 (PIWIL-2) and DEAD Box Helicase-4 (DDX-4) genes. Türk Onkoloji Dergisi. 2021; 36(2): 139 - 145. 10.5505/tjo.2021.2603
IEEE CAG M,ÖZDEMİR Y,ÖZKUL Y "New Molecular Markers in Breast Cancer; Piwi-like protein-2 (PIWIL-2) and DEAD Box Helicase-4 (DDX-4) genes." Türk Onkoloji Dergisi, 36, ss.139 - 145, 2021. 10.5505/tjo.2021.2603
ISNAD CAG, MURAT vd. "New Molecular Markers in Breast Cancer; Piwi-like protein-2 (PIWIL-2) and DEAD Box Helicase-4 (DDX-4) genes". Türk Onkoloji Dergisi 36/2 (2021), 139-145. https://doi.org/10.5505/tjo.2021.2603